Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Jane Macaskill

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
The British Journal of Radiology|January 24, 2020
Mode of presentation and skin thickening on ultrasound may predict nodal burden in breast cancer patients with a positive axillary core biopsyWen Ling Choong, Andrew Evans, Colin A Purdie, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|December 28, 2019
Breast MRI and tumour biology predict axillary lymph node response to neoadjuvant chemotherapy for breast cancerSamia Al-Hattali, Sarah J Vinnicombe, Nazleen Muhammad Gowdh, et al.
Breast Cancer Research and Treatment|May 19, 2010
Gene expression profiling of response to mTOR inhibitor everolimus in pre-operatively treated post-menopausal women with oestrogen receptor-positive breast cancerVicky S Sabine, Andrew H Sims, E Jane Macaskill, et al.
Journal of Clinical Pathology|October 26, 2010
Management of in situ lobular neoplasia detected on needle core biopsy of breastColin A Purdie, Denis McLean, Elizabeth Stormonth, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 3, 2007
DCIS and aromatase inhibitorsJ Michael Dixon, Dana Faratian, Sharon White, et al.
Breast Cancer Research and Treatment|February 12, 2008
Increase in response rate by prolonged treatment with neoadjuvant letrozoleJ Michael Dixon, Lorna Renshaw, E Jane Macaskill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2008
Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancerJ Michael Dixon, Lorna Renshaw, Oliver Young, et al.
Trials|June 7, 2020
Optimisation of the ActWELL lifestyle intervention programme for women attending routine NHS breast screening clinicsAnnie S Anderson, Angela M Craigie, Stephanie Gallant, et al.
Breast Cancer Research and Treatment|September 8, 2010
Anastrozole and letrozole: an investigation and comparison of quality of life and tolerabilityJ Michael Dixon, Lorna Renshaw, Carolyn Langridge, et al.
BMC Genomics|February 26, 2010
Correcting for intra-experiment variation in Illumina BeadChip data is necessary to generate robust gene-expression profilesRobert R Kitchen, Vicky S Sabine, Andrew H Sims, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
The British Journal of Radiology|January 24, 2020
Mode of presentation and skin thickening on ultrasound may predict nodal burden in breast cancer patients with a positive axillary core biopsyWen Ling Choong, Andrew Evans, Colin A Purdie, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|December 28, 2019
Breast MRI and tumour biology predict axillary lymph node response to neoadjuvant chemotherapy for breast cancerSamia Al-Hattali, Sarah J Vinnicombe, Nazleen Muhammad Gowdh, et al.
Breast Cancer Research and Treatment|May 19, 2010
Gene expression profiling of response to mTOR inhibitor everolimus in pre-operatively treated post-menopausal women with oestrogen receptor-positive breast cancerVicky S Sabine, Andrew H Sims, E Jane Macaskill, et al.
Journal of Clinical Pathology|October 26, 2010
Management of in situ lobular neoplasia detected on needle core biopsy of breastColin A Purdie, Denis McLean, Elizabeth Stormonth, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 3, 2007
DCIS and aromatase inhibitorsJ Michael Dixon, Dana Faratian, Sharon White, et al.
Breast Cancer Research and Treatment|February 12, 2008
Increase in response rate by prolonged treatment with neoadjuvant letrozoleJ Michael Dixon, Lorna Renshaw, E Jane Macaskill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2008
Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancerJ Michael Dixon, Lorna Renshaw, Oliver Young, et al.
Trials|June 7, 2020
Optimisation of the ActWELL lifestyle intervention programme for women attending routine NHS breast screening clinicsAnnie S Anderson, Angela M Craigie, Stephanie Gallant, et al.
Breast Cancer Research and Treatment|September 8, 2010
Anastrozole and letrozole: an investigation and comparison of quality of life and tolerabilityJ Michael Dixon, Lorna Renshaw, Carolyn Langridge, et al.
BMC Genomics|February 26, 2010
Correcting for intra-experiment variation in Illumina BeadChip data is necessary to generate robust gene-expression profilesRobert R Kitchen, Vicky S Sabine, Andrew H Sims, et al.
Pageof 3